Literature DB >> 27907955

Decompressive Craniectomy in Neurocritical Care.

Erik G Hayman1, David B Kurland1, Zachary Grunwald2, Sebastian Urday2, Kevin N Sheth2, J Marc Simard1.   

Abstract

Neurosurgeons increasingly use decompressive craniectomy (DC) in neurocritical care. In this review, the authors summarize the topic of DC for the neurointensivist. Following a brief overview of the procedure, the major indications for the procedure are described. This includes a review of the literature regarding well-established indications, such as infarction and traumatic brain injury, as well as lesser known indications, including intracerebral hemorrhage, ruptured cerebrovascular malformations, sinus thrombosis, and infection. Complications unique to DC, specifically syndrome of the trephined, hygroma, and hydrocephalus, also are reviewed with a discussion of their management, both in the immediate and the postoperative period. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27907955     DOI: 10.1055/s-0036-1592170

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  3 in total

1.  Effectiveness and Safety of Pressure Dressings on Reducing Subdural Effusion After Decompressive Craniectomy.

Authors:  Wanyong Huang; Bo Zhou; Yingwei Li; Yuansheng Shao; Bo Peng; Xianchun Jiang; Tao Xiang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-14       Impact factor: 2.570

2.  Outcome of Decompressive Craniectomy in Traumatic Closed Head Injury.

Authors:  Altaf Ali Laghari; Muhammad Ehsan Bari; Muhammad Waqas; Syed Ijlal Ahmed; Karim Rizwan Nathani; Wardah Moazzam
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec

3.  Cranioplasty following ventriculoperitoneal shunting: lessons learned.

Authors:  Dorian Hirschmann; Beate Kranawetter; Constanze Kirchschlager; Matthias Tomschik; Jonathan Wais; Fabian Winter; Matthias Millesi; Johannes Herta; Karl Roessler; Christian Dorfer
Journal:  Acta Neurochir (Wien)       Date:  2020-10-03       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.